Canaccord Genuity on Lucid Diagnostics Inc (LUCD): 'we believe the stock does not reflect the company's long-term growth potential'
Canaccord Genuity analyst Kyle Mikson reiterated a Buy rating and $3.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)